Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000697791 | SCV000826422 | uncertain significance | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2018-08-05 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with serine at codon 2199 of the FBN1 protein (p.Gly2199Ser). The glycine residue is moderately conserved and there is a small physicochemical difference between glycine and serine. This variant is present in population databases (rs770132403, ExAC 0.006%). This variant has been observed in an individual with aortic dissection (PMID: 28973303). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ai |
RCV002223916 | SCV002503170 | uncertain significance | not provided | 2021-12-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999672 | SCV004840108 | uncertain significance | Marfan syndrome | 2024-08-08 | criteria provided, single submitter | clinical testing |